A Phase 4 interventional study of Lactoferrin Bovine and Ferrous Sulfate in Iron Deficiency Anemia Treatment, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 2 Years to 15 Years. Per ClinicalTrials.gov, last updated 2020-02-13.
Sponsored by Assiut University · Phase 4, Interventional, and Treatment
Lactoferrin (Lf) is a mammalian cationic iron binding glycoprotein belonging to the transferrin family which was discovered 70 years ago, and isolated simultaneously from human and bovine milks in 1960. It is widely distributed in all biological fluids and is also expressed by immune cells, which release it under stimulation by pathogens
1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.
This study's enrollment of 96 is close to the median of 94 across 1,291 interventional studies indexed under Anemia.
Browse Anemia studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:all patients with iron deficiency anemia from 2 to 15 years old
-
Exclusion Criteria:
Oral bovine lactoferrin (bfl) 100 mg once daily on empty stomach
Drug: Lactoferrin Bovine
Oral ferrous sulfate 3-6 mg/kg of elemental iron/day in divided doses
Drug: Ferrous Sulfate
combined therapy (both lactoferrin and ferrous sulfate)
Drug: Lactoferrin Bovine · Drug: Ferrous Sulfate
treatment for 30 days
Also known as: Pravotin sachet
treatment for 30 days
Also known as: ferrovit syrup
comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia.
Complete blood count will be done before and after therapy to detect the effect of the therapy on serum hemoglobin(g/d)
Time frame: 30 days
Comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia.
Total serum iron(ug/d) will be done before and after therapy to detect effect of the therapy on total serum iron level (ug/d)
Time frame: 30 days
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University